Global Pharmaceutical Filtration Market to Grow Around $ 41.5 Bn By 2030

The global pharmaceutical filtration market size was worth around USD 10.5 Billion in 2021 and is predicted to grow to around USD 41.5 Billion by 2030 with a compound annual growth rate (CAGR) of roughly 16.5% between 2022 and 2030.

Filters, which are also known as active pharmaceutical components, are used at numerous phases of the production process of small molecule pharmaceuticals (APIs). They aid in the removal or reduction of microorganisms and particulates in process components. The filters are mostly used to keep the process solutions clean while they are kept in tanks. Pharmaceutical filtration can be found in a variety of applications, including final product processing, cell separation, water purification, raw material filtering, and air purification.

The key factors that are augmenting the global market for pharmaceutical filtration are the growing production of large molecules and biologics, proliferation in the generics market, technological progress in nanofibers, and regulatory protocols for cleanrooms in the production of pharmaceuticals.

Other reasons for the increase in the global pharmaceutical filtration industry demand are development in biopharmaceutical companies and a rise in the expenditure on activities of research. There are various challenges that the global pharmaceutical filtration market is facing. Among them, one is the cost control pressures. For cost efficiency, the companies need to collaborate with committed suppliers owing to the several filters that are used during the production of APIs to increase revenue. Other factors that are hampering the market are the strict regulations that are implemented to validate the filtration process and the massive capital that is required to set up the new production facilities.

The global pharmaceutical filtration market is segmented based on product, system, type, technique, application, scale of operation, and region.

Based on the product, the global market is bifurcated into membrane filters, prefilters & depth media, single-use systems, cartridges & capsules, filter holders, filtration accessories, and others. The membrane filters segment is expected to hold the largest market share over the forecast period due to the fast expansion of the pharmaceutical and biologics industries.

To increase their market share as much as possible, these companies are engaging in partnerships and collaborations. For instance, Novartis and Xencor Inc. collaborated strategically in June 2016 to provide Novartis with the right to create T-cell-engaging, bispecific antibodies for the treatment of B-cell and acute myeloid leukemia.

The production and development procedures, including sterile filtration and end-stage operations, frequently employ membrane filters. Thus, the need for cutting-edge medications and vaccinations is anticipated to expand significantly soon due to the rise in the occurrence of viral and chronic diseases including anthrax, measles, influenza, TB, and chickenpox. The CDC estimates that between 5 and 20 percent of Americans get the flu each year.

Based on the system, the market is segmented into single-use and reusable.

Based on the type, the market is segmented into sterile and non-sterile.

Based on the technique, the market is bifurcated into microfiltration, ultrafiltration, crossflow filtration, nanofiltration, and others. Microfiltration holds the largest revenue share over the forecast period. Macromolecules, colloids, and suspended particles can all be concentrated, purified, or separated from the solution using the pressure-driven separation technique known as microfiltration (MF). It is often employed to cold sterilize medications.

It has been demonstrated that adding heat reduces the efficacy of medications. To sterilize liquids without using heat, MF membranes are used in a process known as "cold sterilization" to eliminate bacteria and other undesirable substances. As pharmaceutical research and drug development have risen in recent decades, so has the utilization of microfiltration technology. As a result, microfiltration has taken center stage in pharmaceutical research and development, and demand for the technology is only going to grow in the coming years.

Based on the application, global pharmaceutical filtration is divided into final product processing, raw material filtration, cell separation, water purification, and air purification.

Based on the scale of operation, the global market is segmented into manufacturing scale, pilot-scale, and research & development scale. The manufacturing scale of operations retained the highest market share in 2021 as a result of the rise in the manufacture of biopharmaceuticals, generic medications, and vaccines that are used to treat a variety of ailments.

Due to the rising need for innovative biologics and therapeutic proteins for the treatment of chronic diseases, the manufacturing scale of operations is anticipated to flourish over the forecast period as well. The segment's expansion is anticipated to be aided by the increased prevalence of chronic disorders including cancer, arthritis, and diabetes.

The CDC reports that there are around 54 million arthritis patients in the United States. As a result, there is a significant need for downstream processing products that are effective and productive, which is expected to promote growth.

The North American region contributed the most to the global pharmaceutical filtration market due to the presence of significant pharmaceutical and biopharmaceutical businesses such as Hoffmann-La Roche Ltd, Pfizer Inc., Merck KGaA, and Amgen Inc. The region's well-developed healthcare infrastructure and easy access to cutting-edge technologies have supported the regional market expansion. Besides, the Asia Pacific is expected to grow at the highest CAGR during the forecast period.  

This review is based on a report by Zion Market Research, titled “Pharmaceutical Filtration Market By Product (Membrane Filters, Prefilters & Depth Media, Single-use Systems, Cartridges & Capsules, Filter Holders, Filtration Accessories, and Others), By System (Single-Use and Reusable), By Type (Sterile and Non-Sterile), By Technique (Microfiltration, Ultrafiltration, Crossflow Filtration, Nanofiltration, and Others), By Application (Final Product Processing, Raw Material Filtration, Cell Separation, Water Purification, and Air Purification), By Scale of Operation (Manufacturing Scale, Pilot-scale, and Research & Development Scale), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2030.”- Report at https://www.zionmarketresearch.com/report/pharmaceutical-filtration-market

Recent Development:

• In January 2021, the 3M Petrifilm Plate Reader Advanced was unveiled by 3M Food Safety to speed up production and free up lab testing time. According to the company, food safety specialists may quickly and accurately visualize, count, and record microbial colonies on 3M Petrifilm Plates indication tests using automated technology.

The global pharmaceutical filtration market is dominated by players like:

• Danaher
• GE Healthcare
• GEA Group
• Graver Technologies
• Merck Millipore
• Parker Hannifin Corporation
• Repligen Corporation
• Sartorius Stedim Biotech
• Thermo Fisher Scientific
• 3M
• Eaton
• Antylia Scientific (Cole-Parmer)

The global pharmaceutical filtration market is segmented as follows:

By Product

• Membrane Filters
• Prefilters & Depth Media
• Single-use Systems
• Cartridges & Capsules
• Filter Holders
• Filtration Accessories
• Others

By System

• Single Use
• Reusable

By Type

• Sterile
• Non Sterile

By Technique

• Microfiltration
• Ultrafiltration
• Crossflow Filtration
• Nanofiltration
• Others

By Application

• Final Product Processing
• Raw Material Filtration
• Cell Separation
• Water Purification
• Air Purification

By Scale of Operation

• Manufacturing Scale
• Pilot-scale
• Research & Development Scale

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com